Business Context and Reporting Period
This Form 8-K filing by Akebia Therapeutics, Inc. covers the date of March 25, 2014. The report details corporate governance actions taken in connection with the consummation of the Company's initial public offering (IPO).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate structural changes rather than financial performance data.
Material Changes
- Restated Certificate of Incorporation: Filed with the Delaware Secretary of State and effective as of 10:36 a.m. on March 25, 2014. Key provisions include:
- Authorization of 175 million shares of common stock.
- Elimination of all references to previously existing series of preferred stock.
- Authorization of 25 million shares of undesignated preferred stock for future issuance.
- Amended and Restated By-Laws: Became effective immediately upon the consummation of the IPO. Key provisions include:
- Elimination of the ability for stockholders to take action by written consent in lieu of a meeting.
- Establishment of procedures for stockholder proposals and director nominations.
- Modification of indemnification provisions for directors and officers.
- Preferred Stock Conversion: All previously outstanding shares of preferred stock were mandatorily converted into common stock effective March 25, 2014, based on applicable conversion rates.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, operational outlook, or specific risk factors. The document serves as a notification of the legal and structural changes required to finalize the IPO.
Key Facts for Investor Verification
- Verify the total number of authorized common shares (175 million) and undesignated preferred shares (25 million) in the Restated Certificate.
- Confirm the elimination of written consent rights for stockholders under the new By-Laws.
- Review the conversion rates applied to the mandatory conversion of preferred stock to common stock.
- Examine the attached exhibits (3.1 and 3.2) for the full legal text of the Restated Certificate and By-Laws.